Arachidonic acid activates NLRP3 inflammasome in MDSCs via FATP2 to promote post-transplant tumour recurrence in steatotic liver grafts

Younossi, 2019, Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, Hepatology, 69, 2672, 10.1002/hep.30251 Linares, 2019, Steatosis in liver transplantation: current limitations and future strategies, Transplantation, 103, 78, 10.1097/TP.0000000000002466 Jackson, 2019, Liver transplantation using steatotic grafts, Clin Liver Dis, 14, 191, 10.1002/cld.847 Liu, 2022, Compromised AMPK-PGC1α axis exacerbated steatotic graft injury by dysregulating mitochondrial homeostasis in living donor liver transplantation, Ann Surg, 276, e483, 10.1097/SLA.0000000000004468 Orci, 2016, Effect of ischaemic preconditioning on recurrence of hepatocellular carcinoma in an experimental model of liver steatosis, Br J Surg, 103, 417, 10.1002/bjs.10080 Liu, 2021, New insights in mechanisms and therapeutics for short- and long-term impacts of hepatic ischemia reperfusion injury post liver transplantation, Int J Mol Sci, 22, 8210, 10.3390/ijms22158210 Van Der Bilt, 2005, Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model, Hepatology, 42, 165, 10.1002/hep.20739 Li, 2016, CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation, J Hepatol, 65, 944, 10.1016/j.jhep.2016.05.032 Gabrilovich, 2009, Myeloid-derived suppressor cells as regulators of the immune system, Nat Rev Immunol, 9, 162, 10.1038/nri2506 Liu, 2007, Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host, Blood, 109, 4336, 10.1182/blood-2006-09-046201 Huang, 2006, Gr-1+ CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host, Cancer Res, 66, 1123, 10.1158/0008-5472.CAN-05-1299 Sinha, 2007, Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response, J Immunol, 179, 977, 10.4049/jimmunol.179.2.977 Condamine, 2015, Regulation of tumor metastasis by myeloid-derived suppressor cells, Annu Rev Med, 66, 97, 10.1146/annurev-med-051013-052304 Hossain, 2015, Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances cancer therapies, Cancer Immunol Res, 3, 1236, 10.1158/2326-6066.CIR-15-0036 Al-Khami, 2017, Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells, Oncoimmunology, 6, 10.1080/2162402X.2017.1344804 Condamine, 2016, Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients, Sci Immunol, 1, aaf8943, 10.1126/sciimmunol.aaf8943 Veglia, 2019, Fatty acid transport protein 2 reprograms neutrophils in cancer, Nature, 569, 73, 10.1038/s41586-019-1118-2 Liu, 2021, Monocytic MDSC mobilization promotes tumor recurrence after liver transplantation via CXCL10/TLR4/MMP14 signaling, Cell Death Dis, 12, 489, 10.1038/s41419-021-03788-4 Martinon, 2002, The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β, Mol Cell, 10, 417, 10.1016/S1097-2765(02)00599-3 Szabo, 2015, Inflammasome activation and function in liver disease, Nat Rev Gastroenterol Hepatol, 12, 387, 10.1038/nrgastro.2015.94 Csak, 2011, Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells, Hepatology, 54, 133, 10.1002/hep.24341 Mridha, 2017, NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice, J Hepatol, 66, 1037, 10.1016/j.jhep.2017.01.022 Liu, 2017, NLRP3 inflammasome induced liver graft injury through activation of telomere-independent RAP1/KC axis, J Pathol, 242, 284, 10.1002/path.4901 Zhu, 2011, Gene silencing of NALP3 protects against liver ischemia–reperfusion injury in mice, Hum Gene Ther, 22, 853, 10.1089/hum.2010.145 Wei, 2014, Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression, Lab Invest, 94, 52, 10.1038/labinvest.2013.126 Bruchard, 2013, Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth, Nat Med, 19, 57, 10.1038/nm.2999 Man, 2001, Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes, Arch Surg, 136, 280, 10.1001/archsurg.136.3.280 Cheng, 2010, Distinct mechanism of small-for-size fatty liver graft injury – Wnt4 signaling activates hepatic stellate cells, Am J Transpl, 10, 1178, 10.1111/j.1600-6143.2010.03102.x Ling, 2014, Post-transplant endothelial progenitor cell mobilization via CXCL10/CXCR3 signaling promotes liver tumor growth, J Hepatol, 60, 103, 10.1016/j.jhep.2013.08.017 Pang, 2022, Postoperative plasmacytoid dendritic cells secrete IFNα to promote recruitment of myeloid-derived suppressor cells and drive hepatocellular carcinoma recurrence, Cancer Res, 82, 4206, 10.1158/0008-5472.CAN-22-1199 Zhang, 2009, Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients, J Hepatol, 50, 980, 10.1016/j.jhep.2008.12.033 Bronte, 2016, Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards, Nat Commun, 7, 10.1038/ncomms12150 Huang, 2014, Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages, Nat Immunol, 15, 846, 10.1038/ni.2956 Herber, 2010, Lipid accumulation and dendritic cell dysfunction in cancer, Nat Med, 16, 880, 10.1038/nm.2172 Pan, 2018, Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release, Cell Immunol, 332, 111, 10.1016/j.cellimm.2018.08.006 Ijaz, 2003, Impairment of hepatic microcirculation in fatty liver, Microcirculation, 10, 447, 10.1038/sj.mn.7800206 Fukumori, 1997, Why is fatty liver unsuitable for transplantation? Deterioration of mitochondrial ATP synthesis and sinusoidal structure during cold preservation of a liver with steatosis, Transpl Proc, 29, 4125, 10.1016/S0041-1345(96)00158-3 Chu, 2013, The impact of hepatic steatosis on hepatic ischemia–reperfusion injury in experimental studies: a systematic review, Biomed Res Int, 2013, 10.1155/2013/192029 Videla, 1988, Biochemical aspects of cellular oxidative stress, Arch Biol Med Exp, 21, 85 Chouchani, 2014, Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS, Nature, 515, 431, 10.1038/nature13909 Wijermars, 2016, Succinate accumulation and ischemia–reperfusion injury: of mice but not men, a study in renal ischemia–reperfusion, Am J Transpl, 16, 2741, 10.1111/ajt.13793 Falcon, 2010, FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase, Am J Physiol Endocrinol Metab, 299, E384, 10.1152/ajpendo.00226.2010 Cheng, 2014, The roles of lipocalin-2 in small-for-size fatty liver graft injury, Ann Surg, 260, 1062, 10.1097/SLA.0000000000000427 Mueller, 2020, Hypothermic oxygenated liver perfusion (HOPE) prevents tumor recurrence in liver transplantation from donation after circulatory death, Ann Surg, 272, 759, 10.1097/SLA.0000000000004258 Kron, 2018, Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans, J Hepatol, 68, 82, 10.1016/j.jhep.2017.08.028 Bending, 2009, Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice, J Clin Invest, 119, 565, 10.1172/JCI37865 Ye, 2011, Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-γ+ and FOXP3+ T cells with potent suppressive function, Eur J Immunol, 41, 936, 10.1002/eji.201040682 Gu, 2011, IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma, Mol Cancer, 10, 150, 10.1186/1476-4598-10-150 Yu, 2007, Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment, Nat Rev Immunol, 7, 41, 10.1038/nri1995